Changes in Metabolic Syndrome and Its Components and the Risk of Type 2 Diabetes: a Nationwide Cohort Study

Overview

Journal Sci Rep

Specialty Science

Date 2020 Feb 13

PMID 32047219

Citations 50

Authors

Min-Kyung Lee

Kyungdo Han

Mee Kyoung Kim

Eun Sil Koh

Eun Sook Kim

Ga Eun Nam

Hyuk-Sang Kwon

Affiliations

Soon will be listed here.

Abstract

We investigated the relationship of changes in Metabolic syndrome (MetS) and its components with the risk of type 2 diabetes (T2D) in South Korea. Records of 10,806,716 adults aged ≥ 20 years without a history of T2D between 2009 and 2015 were retrieved from database of the South Korean National Health Insurance Service and analyzed. Changes in metabolic components were monitored over a two-year period with follow-up occurring at an average of 4.087 years. During the follow-up period, 848,859 individuals were diagnosed with T2D. The risk of diabetes was lowered with a decrease in the number of MetS components at baseline and the second visit (p for trend <0.0001). Multivariable-adjusted HRs for incident diabetes were 0.645 among individuals with reduced number of MetS components, 0.54 for those with improvement in elevated fasting glucose, 0.735 for those with improvement in elevated triglycerides, 0.746 for those with improvement in elevated blood pressure, 0.763 for those with improvement in reduced HDL-cholesterol, and 0.92 for those with improvement in abdominal obesity compared with those manifesting them at both time points. In conclusion, changes in metabolic syndrome and its components were significantly associated with the development of T2D. Improvement in MetS and its components attenuated the risk of diabetes.

Citing Articles

Association between the systemic immune-inflammation index and metabolic syndrome and its components: results from the multi-ethnic study of atherosclerosis (MESA).

Ramezankhani A, Tohidi M, Hadaegh F Cardiovasc Diabetol. 2025; 24(1):78.

PMID: 39955525 PMC: 11830208. DOI: 10.1186/s12933-025-02629-4.

Association between the C-reactive protein-albumin-lymphocyte index and metabolic syndrome: evidence from the 2003-2010 national health and nutrition examination survey.

Wu L, Han D, Xue Y, He S, Ma Z, Su S Diabetol Metab Syndr. 2025; 17(1):39.

PMID: 39891279 PMC: 11783767. DOI: 10.1186/s13098-025-01609-8.

Ferulic acid restores mitochondrial dynamics and autophagy via AMPK signaling pathway in a palmitate-induced hepatocyte model of metabolic syndrome.

Li Y, Zhao W, Sair A, Li T, Liu R Sci Rep. 2024; 14(1):18970.

PMID: 39152139 PMC: 11329500. DOI: 10.1038/s41598-024-66362-w.

The multimorbidity association of metabolic syndrome and depression on type 2 diabetes: a general population cohort study in Southwest China.

Cai Y, Zhou S, Fan S, Yang Y, Tian K, Luo L Front Endocrinol (Lausanne). 2024; 15:1399859.

PMID: 39036053 PMC: 11257852. DOI: 10.3389/fendo.2024.1399859.

Comparison of Heart Rate Variability in Thai Older Adults with Hypertension, Pre-Hypertension, and Normotension.

Sri-Amad R, Huipao N, Sriwannawit P, Prasertsri P, Roengrit T ScientificWorldJournal. 2024; 2024:9631390.

PMID: 38808160 PMC: 11132811. DOI: 10.1155/2024/9631390.

References

Wu Y, Ding Y, Tanaka Y, Zhang W . Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014; 11(11):1185-200. PMC: 4166864. DOI: 10.7150/ijms.10001. View

Siegel K, Bullard K, Imperatore G, Ali M, Albright A, Mercado C . Prevalence of Major Behavioral Risk Factors for Type 2 Diabetes. Diabetes Care. 2018; 41(5):1032-1039. PMC: 6436527. DOI: 10.2337/dc17-1775. View

Simmons R, Alberti K, Gale E, Colagiuri S, Tuomilehto J, Qiao Q . The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2009; 53(4):600-5. DOI: 10.1007/s00125-009-1620-4. View

Huang P . A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5-6):231-7. PMC: 2675814. DOI: 10.1242/dmm.001180. View

Sattar N, McConnachie A, Shaper A, Blauw G, Buckley B, de Craen A . Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008; 371(9628):1927-35. DOI: 10.1016/S0140-6736(08)60602-9. View

Hanson R, Imperatore G, Bennett P, Knowler W . Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes. 2002; 51(10):3120-7. DOI: 10.2337/diabetes.51.10.3120. View

Nakanishi N, Takatorige T, Fukuda H, Shirai K, Li W, Okamoto M . Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract. 2004; 64(1):59-70. DOI: 10.1016/j.diabres.2003.10.001. View

Shin J, Lee J, Lim S, Ha H, Kwon H, Park Y . Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig. 2014; 4(4):334-43. PMC: 4020225. DOI: 10.1111/jdi.12075. View

Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112(17):2735-52. DOI: 10.1161/CIRCULATIONAHA.105.169404. View

10.

Seong S, Kim Y, Khang Y, Park J, Kang H, Lee H . Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol. 2016; 46(3):799-800. PMC: 5837262. DOI: 10.1093/ije/dyw253. View

11.

Song S, Jung C, Song Y, Park C, Kwon H, Cha B . Background and data configuration process of a nationwide population-based study using the korean national health insurance system. Diabetes Metab J. 2014; 38(5):395-403. PMC: 4209354. DOI: 10.4093/dmj.2014.38.5.395. View

12.

Alberti K, Eckel R, Grundy S, Zimmet P, Cleeman J, Donato K . Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation;.... Circulation. 2009; 120(16):1640-5. DOI: 10.1161/CIRCULATIONAHA.109.192644. View

13.

Lee S, Park H, Kim D, Han J, Kim S, Cho G . Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract. 2006; 75(1):72-80. DOI: 10.1016/j.diabres.2006.04.013. View

14.

Lee S, Han K, Kang Y, Kim S, Cho Y, Ko K . Trends in the prevalence of metabolic syndrome and its components in South Korea: Findings from the Korean National Health Insurance Service Database (2009-2013). PLoS One. 2018; 13(3):e0194490. PMC: 5864027. DOI: 10.1371/journal.pone.0194490. View

15.

Wang K, Yang Q, Chen X, Liu Y, Shan S, Zheng H . Metabolic Syndrome and Its Components Predict the Risk of Type 2 Diabetes Mellitus in the Mainland Chinese: A 3-Year Cohort Study. Int J Endocrinol. 2019; 2018:9376179. PMC: 6311882. DOI: 10.1155/2018/9376179. View

16.

Noble D, Mathur R, Dent T, Meads C, Greenhalgh T . Risk models and scores for type 2 diabetes: systematic review. BMJ. 2011; 343:d7163. PMC: 3225074. DOI: 10.1136/bmj.d7163. View

17.

Tabak A, Herder C, Rathmann W, Brunner E, Kivimaki M . Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379(9833):2279-90. PMC: 3891203. DOI: 10.1016/S0140-6736(12)60283-9. View

18.

Mozaffary A, Asgari S, Tohidi M, Kazempour-Ardebili S, Azizi F, Hadaegh F . Change in fasting plasma glucose and incident type 2 diabetes mellitus: results from a prospective cohort study. BMJ Open. 2016; 6(5):e010889. PMC: 4885425. DOI: 10.1136/bmjopen-2015-010889. View

19.

Nichols G, Hillier T, Brown J . Progression from newly acquired impaired fasting glusose to type 2 diabetes. Diabetes Care. 2007; 30(2):228-33. PMC: 1851903. DOI: 10.2337/dc06-1392. View

20.

Lorenzo C, Williams K, Hunt K, Haffner S . The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2006; 30(1):8-13. DOI: 10.2337/dc06-1414. View